Similar articles

• Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans.

  Tempero KF, Cirillo VJ, Steelman SL. Tempero KF, et al. Br J Clin Pharmacol. 1977 Feb;4 Suppl 1(Suppl 1):31S-36S. doi: 10.1111/j.1365-2125.1977.tb04511.x. Br J Clin Pharmacol. 1977. PMID: 328032 Free PMC article. Review.
• Diabetes in the population.

  Malins JM. Malins JM. Clin Endocrinol Metab. 1972 Nov;1(3):645-72. doi: 10.1016/s0300-595x(72)80038-0. Clin Endocrinol Metab. 1972. PMID: 4589701 Review. No abstract available.
• Drug interactions with oral anticoagulants.

  Ahmad S. Ahmad S. Postgrad Med. 1980 Jan;67(1):47-8. doi: 10.1080/00325481.1980.11715334. Postgrad Med. 1980. PMID: 7350566 No abstract available.
• Drug interactions involving oral anticoagulants.

  O'Reilly RA. O'Reilly RA. Cardiovasc Clin. 1974;6(2):23-41. Cardiovasc Clin. 1974. PMID: 4613460 Review. No abstract available.
• Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism.

  Donnelly R, Morris AD. Donnelly R, et al. Br J Clin Pharmacol. 1994 Apr;37(4):311-20. doi: 10.1111/j.1365-2125.1994.tb04283.x. Br J Clin Pharmacol. 1994. PMID: 7912538 Free PMC article. Review. No abstract available.